Baptiste Abbar

15PUBLICATIONS
64CO-AUTHORS
Cellular immunologyMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 06, 2026
Restarting Immune Checkpoint Inhibitors After ICI Myocarditis: A Prospective Cohort.

Naim Jebnoun, Marie Bretagne, Michelle Rosenzwajg

|Nov 19, 2025
Response to Letters Regarding "Comedications Associated with Immune-Related Adverse Events from Immune-Checkpoint Inhibitors".

Léonard Laurent, Baptiste Abbar, Paul Gougis

|Nov 14, 2025
Doxorubicin paclitaxel in pretreated advanced small-cell lung cancer: a large real-life retrospective study.

Coraline Cheuvart, Paul Gougis, Luca Campedel

|Jun 19, 2025
Sacituzumab govitecan: a new hope for patients with pretreated extensive small-cell lung cancer (SCLC)-insights from the TROPiCS-03 trial.

Baptiste Abbar, Frank Aboubakar Nana, Jean Philippe Spano

|Jun 16, 2025
Comedications Associated with Immune-Related Adverse Events from Immune-Checkpoint Inhibitors.

Léonard Laurent, Baptiste Abbar, Kevin Bihan

Pageof 3